Dr. Lin, Yi-Ling
Distinguished Research Fellow
Division Chief
- 02-2789-9013 (Lab) (Room No: 443)
- 02-2652-3902
- 02-2785-8847 (Fax)
-
Specialty:
- Molecular Virology
- Viral Pathogenesis
- Viral Immunology
Education and Positions:
1992/12, PhD, University of California, Los Angeles (UCLA), USA
2014/7-2018/9, Deputy Director, IBMS, AS, Taipei, Taiwan
2020/9-2024/8, CEO, Emerging Infectious Disease Division (EIDD), Biomedical Translation Research Center (BioTReC), AS, Taipei, Taiwan
Highlight Detail
Surfactant-modified nanoclay exhibits an antiviral activity with high potency and broad spectrum.
Dr. Lin, Yi-Ling
J Virol., Jan 29, 2014The IFN immune system comprises type I, II, and III IFNs, signals through the JAK-STAT pathway, and plays central roles in host defense against viral infection. Posttranslational modifications such as ubiquitination regulate diverse molecules in the IFN pathway. To search for the deubiquitinating enzymes (DUBs) involved in the antiviral activity of IFN,